AIM
AVNS icon

Acrospire Investment Management’s Avanos Medical AVNS Stock Holding History

Acrospire Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,458
Closed -$57K – 126
2017
Q2 		$57K Sell
1,458
-800
-35% -$30.2K 0.05% 719
2017
Q1 		$86K Sell
2,258
-5,300
-70% -$207K 0.07% 433
2016
Q4 		$279K Buy
7,558
+521
+7% +$18.6K 0.11% 174
2016
Q3 		$244K Buy
7,037
+1,187
+20% +$41.6K 0.16% 73
2016
Q2 		$190K Buy
+5,850
New +$179K 0.14% 100

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Acrospire Investment Management's AVNS Position: Q3 2017 in Review

Acrospire Investment Management sold out of Avanos Medical (AVNS) in Q3 2017, closing a stake of 1,458 shares — an estimated $57K sold.

Acrospire Investment Management first reported a position in AVNS in Q2 2016 and held it in 5 quarters. The position peaked at $279K in Q4 2016. 318 funds tracked by Wall St. Rank hold AVNS as of Q3 2017.

  • Acrospire Investment Management reported no remaining Avanos Medical position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,458 Avanos Medical shares in Q3 2017, an estimated $57K.
  • Acrospire Investment Management first reported a position in Avanos Medical in Q2 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Avanos Medical position peaked at $279K in Q4 2016.
  • 318 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.